Note 15 - Segments and Geographic Areas

9 Months Ended

Sep. 30, 2023

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

15. Segments and Geographic Areas

The Company operates in one business segment—the research, development, and sale of medical devices to improve minimally invasive surgery. The Company’s chief operating decision maker (determined to be the Chief Executive Officer) does not manage any part of the Company separately, and the allocation of resources and assessment of performance are based on the Company’s consolidated operating results.

The following table presents long-lived assets (which include property and equipment and operating lease assets) by geographic area:

	September 30, 2023			December 31, 2022
U.S.		37	%		39	%
EMEA		57	%		57	%
Asia		6	%		4	%
Total		100	%		100	%

The following table presents revenue by geographic area based on the country in which the customer is based:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022
US		17	%		7	%		17	%		13	%
EMEA		64	%		86	%		62	%		72	%
Asia		19	%		7	%		21	%		15	%
Total		100	%		100	%		100	%		100	%

For the three months ended September 30, 2023, one customer accounted for more than 10% of revenue. For the nine months ended September 30, 2023, no customers accounted for more than 10% of revenue. For the three and nine months ended September 30, 2022, the Company had one customer who accounted for more than 10% of revenue.